Breaking News Instant updates and real-time market news.

HCLP

Hi-Crush Partners

$8.04

0.1 (1.26%)

17:07
10/30/18
10/30
17:07
10/30/18
17:07

Hi-Crush Partners reports Q3 EPS 29c, consensus 56c

Reports Q3 revenue $214.0M, consensus $223.02M. The company said "The Q3 experienced a rapid change in market conditions in the frac sand sector. This change, attributable to declines in well completion activity and therefore demand for frac sand, impacted the market for Northern White volumes and pricing, which we expect to continue in the fourth quarter. The accelerated pace of slowdown in well completion activity, combined with supply additions and build-up of inventories in-basin, resulted in lower pricing for Northern White sand across all basins. We remain committed to our Mine. Move. Manage. operating strategy and to expanding our frac sand logistics solutions offering. We believe our focus on logistics will differentiate Hi-Crush and continue to benefit unitholders, particularly as the market rebounds in 2019 due to operator budget resets and the alleviation of takeaway capacity constraints in the Permian Basin."

  • 31

    Oct

HCLP Hi-Crush Partners
$8.04

0.1 (1.26%)

10/17/18
JEFF
10/17/18
DOWNGRADE
JEFF
Jefferies downgrades four names on 'sinking' white sand demand
Jefferies analyst Brad Handler downgraded Hi-Crush Partners (HCLP) and Smart Sand (SND) to Underperform from Hold as well as Covia (CVIA) and U.S. Silica (SLCA) to Hold from Buy citing "sinking" Northern white sand demand and prices. The analyst sees the weakness spreading to regional/in-basin sand and ultimately to box/silo-based last-mile solutions as "supply adds overtake demand growth." He also expects the Q3 earnings season to drive downward estimate revisions. Smart Sand, Covia and Hi-Crus have the highest Northern white sand exposure, Handler tells investors in a research note.
10/17/18
JEFF
10/17/18
DOWNGRADE
Target $6
JEFF
Underperform
Hi-Crush Partners downgraded to Underperform from Hold at Jefferies
Jefferies analyst Bradley Handler downgraded Hi-Crush Partners to Underperform and lowered his price target for the shares to $6 from $12.
10/05/18
UBSW
10/05/18
DOWNGRADE
Target $10
UBSW
Neutral
Hi-Crush Partners downgraded to Neutral from Buy at UBS
UBS analyst Sasha Sanwal downgraded Hi-Crush Partners to Neutral and lowered his price target for the shares to $10 from $18. The analyst cites distribution risk and industry headwinds for the downgrade.
10/03/18
10/03/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. HSBC CUTS NIKE TO HOLD: HSBC analyst Erwan Rambourg downgraded Nike (NKE) to Hold from Buy and kept his $92 price target on shares. The analyst noted that while the company's Q1 results were strong and the outlook "remains rock solid", the company's valuation multiple of 30-times forward earnings may weigh on the stock. EVERCORE CUTS ORACLE TO IN LINE: Evercore ISI analyst Kirk Materne downgraded Oracle (ORCL) to In Line from Outperform with a price target of $53 to reflect the update of his model into FY20. The analyst noted that even though growth is expected to accelerate modestly in the second half of this year, there are not enough catalysts for share to "meaningfully re-rate" from current levels, adding that the risk-reward appears balanced following this summer's rally. CIGNA BOOSTED TO CONVICTION BUY AT GOLDMAN: Goldman Sachs analyst Stephen Tanal added Buy-rated Cigna (CI) to his firm's Conviction List and raised his price target for the shares to $250 from $227. After revisiting the company's fundamental story, the analyst continues to believe Cigna is well positioned to take share of the U.S. commercial market. He believes fundamentals support a higher standalone multiple. CREDIT SUISSE DOWNGRADES HI-CRUSH, COVIA: Credit Suisse analyst Jim Wicklund downgraded Hi-Crush Partners (HCLP) to Neutral from Outperform and Covia (CVIA) to Underperform from Neutral. The analyst noted that the weakness that has rippled through the frack sand subsector since August came sooner than he expected. The ferocity of price competition, based on commentary from the sand companies in addition to their OFS and E&P customers, is also greater than he had expected, he added. In late morning trading, Hi-Crush was down almost 2%, while Covia was down just over 4%. GOLDMAN RAISES ALIBABA'S PRICE TARGET: Goldman Sachs analyst Piyush Mubayi reiterated a Buy rating on Alibaba (BABA) and raised his price target to $247 from $241. The analyst predicts strong growth in the cloud computing and financial businesses for the company, and expects Alibaba to continue to invest for future growth on "multiple fronts," including retailing, digital advertising and entertainment, which he believes will be a total addressable market of about RMB80T by the end of 2020.

TODAY'S FREE FLY STORIES

CHL

China Mobile

09:31
11/19/18
11/19
09:31
11/19/18
09:31
Downgrade
China Mobile rating change  »

China Mobile downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHA

China Telecom

09:31
11/19/18
11/19
09:31
11/19/18
09:31
Downgrade
China Telecom rating change  »

China Telecom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$49.91

-1.53 (-2.97%)

, SPB

Spectrum Brands

$59.36

0.87 (1.49%)

09:31
11/19/18
11/19
09:31
11/19/18
09:31
Recommendations
Energizer, Spectrum Brands analyst commentary  »

Energizer price target…

ENR

Energizer

$49.91

-1.53 (-2.97%)

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CTWS

Connecticut Water

$69.51

-0.24 (-0.34%)

09:30
11/19/18
11/19
09:30
11/19/18
09:30
Hot Stocks
Connecticut Water announces $85.7M capital spending plan for 2019 »

Connecticut Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.63

0.14 (3.12%)

09:27
11/19/18
11/19
09:27
11/19/18
09:27
Conference/Events
Ovid Therapeutics management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

TRGP

Targa Resources

$47.44

0.25 (0.53%)

09:26
11/19/18
11/19
09:26
11/19/18
09:26
Upgrade
Targa Resources rating change  »

Targa Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$129.96

0.52 (0.40%)

09:26
11/19/18
11/19
09:26
11/19/18
09:26
Periodicals
Barloworld in talks to purchase a Caterpillar business, Reuters reports »

Barloworld is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

PCG

PG&E

$24.39

6.62 (37.25%)

09:25
11/19/18
11/19
09:25
11/19/18
09:25
Recommendations
PG&E analyst commentary  »

PG&E break-up could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPAY

Bottomline Technologies

$56.47

0.35 (0.62%)

, GDOT

Green Dot

$84.81

1.88 (2.27%)

09:25
11/19/18
11/19
09:25
11/19/18
09:25
Conference/Events
Citigroup financial analysts to hold an analyst/industry conference call »

Financial Analysts review…

EPAY

Bottomline Technologies

$56.47

0.35 (0.62%)

GDOT

Green Dot

$84.81

1.88 (2.27%)

MA

MasterCard

$199.11

-1.7 (-0.85%)

PYPL

PayPal

$85.04

-1.71 (-1.97%)

SQ

Square

$70.55

-3.045 (-4.14%)

V

Visa

$140.25

-1.655 (-1.17%)

WP

Worldpay

$82.05

-0.62 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 12

    Dec

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 29

    Jan

09:25
11/19/18
11/19
09:25
11/19/18
09:25
General news
Breaking General news story  »

New York Federal Reserve…

BYSI

BeyondSpring

$21.42

(0.00%)

09:24
11/19/18
11/19
09:24
11/19/18
09:24
Conference/Events
BeyondSpring management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EMN

Eastman Chemical

$83.11

0.34 (0.41%)

09:22
11/19/18
11/19
09:22
11/19/18
09:22
Recommendations
Eastman Chemical analyst commentary  »

Eastman Chemical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$16.99

0.1 (0.59%)

09:21
11/19/18
11/19
09:21
11/19/18
09:21
Initiation
Yeti initiated  »

William Blair starts Yeti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

09:20
11/19/18
11/19
09:20
11/19/18
09:20
General news
U.S. NAHB housing market index preview: »

U.S. NAHB housing market…

ADS

Alliance Data

$198.00

0.38 (0.19%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Recommendations
Alliance Data analyst commentary  »

Alliance Data price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$13.02

0.005 (0.04%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Hot Stocks
Corcept Therapeutics doses first patient in Phase 3 trial of relacorilant »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Options
Overnight activity included 313 trades in SPX and 10 trades in VIX »

313 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLTZY

Tele2

$0.00

(0.00%)

09:17
11/19/18
11/19
09:17
11/19/18
09:17
Upgrade
Tele2 rating change  »

Tele2 upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$1.23

-0.365 (-22.88%)

09:16
11/19/18
11/19
09:16
11/19/18
09:16
Hot Stocks
Akers Biosciences considering business combinations in cannabis related industry »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$1.08

-0.015 (-1.37%)

09:15
11/19/18
11/19
09:15
11/19/18
09:15
Hot Stocks
Applied DNA Sciences, Eurofins sign collaboration agreement »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$30.51

0.67 (2.25%)

, VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Resolute Energy…

REN

Resolute Energy

$30.51

0.67 (2.25%)

VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

LEJU

Leju

$1.71

0.05 (3.01%)

JD

JD.com

$23.04

-1.18 (-4.87%)

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

PCG

PG&E

$24.39

6.62 (37.25%)

MDGL

Madrigal Pharmaceuticals

$129.47

-3.36 (-2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

IRT

Independence Realty Trust

$9.99

0.21 (2.15%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
Independence Realty Trust initiated  »

Independence Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
American Campus initiated  »

American Campus initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$41.06

0.6 (1.48%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
UDR, Inc. initiated  »

UDR, Inc. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$8.50

(0.00%)

, SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

09:13
11/19/18
11/19
09:13
11/19/18
09:13
Hot Stocks
Immuron appoints Gary Jacob CEO »

Immuron (IMRN) announced…

IMRN

Immuron

$8.50

(0.00%)

SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.